Nav: Home

Uridine diphosphate glucose found to dampen lung cancer metastasis

June 26, 2019

In a study published online in Nature on June 26, research teams led by Dr. YANG Weiwei at the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (CAS) and Dr. LI Guohui from the Dalian Institute of Chemical Physics of CAS reported a new function of uridine diphosphate glucose (UDP-glucose), a metabolic intermediate in the uronic acid pathway: It impairs lung cancer metastasis by accelerating SNAI1 mRNA decay.

This discovery is important because lung cancer is the leading cancer killer in both China and the world, and cancer metastasis is estimated to be responsible for 95% of cancer deaths. Lung cancer alone kills more than 600,000 people each year in China.

Primary malignant tumors can often be effectively treated by traditional therapies such as surgery, radiation and chemotherapy. However, in most cases, traditional therapies have limited effect on metastatic tumors. Therefore, understanding the molecular mechanisms underlying tumor metastasis helps to provide a biomarker for the early detection of tumor metastasis and a new strategy for intervening in metastasis, thus offering patients a better prognosis.

Deregulated metabolism is the hallmark of cancer. Mutations in oncogenes and tumor suppressor genes cause alterations to multiple intracellular signaling pathways that affect tumor cell metabolism and re-engineer it to allow enhanced survival and growth. The unique biochemical microenvironment further influences the metabolic phenotype of tumor cells, and thus affects tumor progression, response to therapy and patient outcome.

This study reveals a unique function of UDP-glucose in impairing tumor metastasis, presents a new model of metabolite-regulated protein function, and establishes a new connection between metabolism and RNA stability.

Specifically, the researchers demonstrated that upon epidermal growth factor receptor (EGFR) activation, UDP-glucose dehydrogenase (UGDH) is phosphorylated at tyrosine (Y) 473. UGDH is the rate-limiting enzyme in the uronic acid pathway. It catalyzes UDP-glucose to produce UDP-glucuronic acid and participates in the biosynthesis of glycosaminoglycan.

Phosphorylated UGDH binds to HuR and converts UDP-glucose into UDP-glucuronic acid, which attenuates UDP-glucose-mediated inhibition on HuR association with SNAI1 mRNA, thereby enhancing SNAI1 mRNA stability. Increased Snail (encoded by SNAI1) expression in turn initiates the epithelial-mesenchymal transition of tumor cells, thus promoting tumor cell migration and lung cancer metastasis.

In addition, the scientists found that lower UDP-glucose levels are closely related to the metastasis and recurrence of lung cancer. They observed that UDP-glucose levels in metastatic tumors were much lower than in primary tumors. Patients with distant metastasis had much lower UDP-glucose levels than those without distant metastasis, and patients with high UGDH Y473 phosphorylation in tumor tissues had a higher rate of metastasis and worse prognosis.

Chinese Academy of Sciences Headquarters

Related Lung Cancer Articles:

AI helps to fight against lung cancer
Lung cancer has been the leading cause of cancer-related deaths in 2015 in United States.
Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings
The first year of free lung cancer screening in the Augusta, Ga., area found more than double the rate seen in a previous large, national study as well as a Massachusetts-based screening for this No.
Antioxidants and lung cancer risk
An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer.
Lung cancer may go undetected in kidney cancer patients
Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C.
Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Huntsman Cancer Institute research holds promise for personalized lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another.
High levels of estrogen in lung tissue related to lung cancer in postmenopausal women
Researchers from Kumamoto University, Japan have found that postmenopausal women with multicentric adenocarcinoma of the lung have a higher concentration of estrogen in non-cancerous areas of the peripheral lung than similar women diagnosed with single tumor lung cancer.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Pericardial window operation less efficient in cases of lung cancer than any other cancer
Pericardial window operation, a procedure, where abnormal quantity of malignant fluid, surrounding the heart, is drained into the neighbouring chest cavity, is commonly applied to patients diagnosed with cancer.

Related Lung Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...